文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

急性失代偿性心力衰竭住院死亡率的风险分层:分类与回归树分析

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

作者信息

Fonarow Gregg C, Adams Kirkwood F, Abraham William T, Yancy Clyde W, Boscardin W John

机构信息

Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, CA 90095, USA.

出版信息

JAMA. 2005 Feb 2;293(5):572-80. doi: 10.1001/jama.293.5.572.


DOI:10.1001/jama.293.5.572
PMID:15687312
Abstract

CONTEXT: Estimation of mortality risk in patients hospitalized with acute decompensated heart failure (ADHF) may help clinicians guide care. OBJECTIVE: To develop a practical user-friendly bedside tool for risk stratification for patients hospitalized with ADHF. DESIGN, SETTING, AND PATIENTS: The Acute Decompensated Heart Failure National Registry (ADHERE) of patients hospitalized with a primary diagnosis of ADHF in 263 hospitals in the United States was queried with analysis of patient data to develop a risk stratification model. The first 33,046 hospitalizations (derivation cohort; October 2001-February 2003) were analyzed to develop the model and then the validity of the model was prospectively tested using data from 32,229 subsequent hospitalizations (validation cohort; March-July 2003). Patients had a mean age of 72.5 years and 52% were female. MAIN OUTCOME MEASURE: Variables predicting mortality in ADHF. RESULTS: When the derivation and validation cohorts are combined, 37,772 (58%) of 65,275 patient-records had coronary artery disease. Of a combined cohort consisting of 52,164 patient-records, 23,910 (46%) had preserved left ventricular systolic function. In-hospital mortality was similar in the derivation (4.2%) and validation (4.0%) cohorts. Recursive partitioning of the derivation cohort for 39 variables indicated that the best single predictor for mortality was high admission levels of blood urea nitrogen (> or =43 mg/dL [15.35 mmol/L]) followed by low admission systolic blood pressure (<115 mm Hg) and then by high levels of serum creatinine (> or =2.75 mg/dL [243.1 micromol/L]). A simple risk tree identified patient groups with mortality ranging from 2.1% to 21.9%. The odds ratio for mortality between patients identified as high and low risk was 12.9 (95% confidence interval, 10.4-15.9) and similar results were seen when this risk stratification was applied prospectively to the validation cohort. CONCLUSIONS: These results suggest that ADHF patients at low, intermediate, and high risk for in-hospital mortality can be easily identified using vital sign and laboratory data obtained on hospital admission. The ADHERE risk tree provides clinicians with a validated, practical bedside tool for mortality risk stratification.

摘要

背景:评估急性失代偿性心力衰竭(ADHF)住院患者的死亡风险可能有助于临床医生指导治疗。 目的:为ADHF住院患者开发一种实用的、便于用户使用的床边风险分层工具。 设计、地点和患者:对美国263家医院中以ADHF为主要诊断住院的患者的急性失代偿性心力衰竭国家注册数据库(ADHERE)进行查询,并分析患者数据以开发风险分层模型。对前33046例住院病例(推导队列;2001年10月至2003年2月)进行分析以开发模型,然后使用32229例后续住院病例(验证队列;2003年3月至7月)的数据对模型的有效性进行前瞻性测试。患者的平均年龄为72.5岁,52%为女性。 主要观察指标:预测ADHF患者死亡的变量。 结果:将推导队列和验证队列合并后,65275例患者记录中有37772例(58%)患有冠状动脉疾病。在由52164例患者记录组成的合并队列中,23910例(46%)左心室收缩功能保留。推导队列(4.2%)和验证队列(4.0%)的院内死亡率相似。对推导队列中的39个变量进行递归划分表明,死亡的最佳单一预测因素是入院时血尿素氮水平高(≥43mg/dL[15.35mmol/L]),其次是入院时收缩压低(<115mmHg),然后是血清肌酐水平高(≥2.75mg/dL[243.1μmol/L])。一个简单的风险树确定了死亡率在2.1%至21.9%之间的患者组。被确定为高风险和低风险患者之间的死亡比值比为12.9(95%置信区间,10.4-15.9),当将这种风险分层前瞻性应用于验证队列时也得到了类似结果。 结论:这些结果表明,使用入院时获得的生命体征和实验室数据可以轻松识别ADHF患者的院内死亡低、中、高风险。ADHERE风险树为临床医生提供了一种经过验证的、实用的床边死亡风险分层工具。

相似文献

[1]
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

JAMA. 2005-2-2

[2]
Risk of in-hospital mortality identified according to the typology of patients with acute heart failure: classification tree analysis on data from the Acute Heart Failure Database-Main registry.

J Crit Care. 2012-11-14

[3]
Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

J Am Coll Cardiol. 2008-8-12

[4]
A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.

Circ Cardiovasc Qual Outcomes. 2010-1

[5]
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.

J Am Coll Cardiol. 2007-5-15

[6]
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

J Am Coll Cardiol. 2006-1-3

[7]
Predictors of in-hospital mortality in acute decompensated heart failure (Thai ADHERE).

J Med Assoc Thai. 2013-2

[8]
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.

Am Heart J. 2015-8

[9]
Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM).

Acad Emerg Med. 2008-2

[10]
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.

Heart. 2013-10-31

引用本文的文献

[1]
Mortality Prediction in Heart Failure Patients: Machine Learning Versus Get With The Guidelines-Heart Failure (GWTG-HF) and Acute Decompensated Heart Failure National Registry (ADHERE).

Cureus. 2025-8-1

[2]
Prognostic Models in Heart Failure: Hope or Hype?

J Pers Med. 2025-8-1

[3]
Predicting ICU mortality in heart failure patients based on blood tests and vital signs.

Front Cardiovasc Med. 2025-6-25

[4]
Clinical, paraclinical, therapeutic features of acute decompensated heart failure in a Moroccan population.

Sci Rep. 2025-7-1

[5]
Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure.

Biomedicines. 2025-6-18

[6]
Hypocapnia and its relationship with in-hospital mortality in acute heart failure patients: Insights from the Indonesian multicenter ICCU registry.

Narra J. 2025-4

[7]
Impact of Angiotensin Receptor-Neprilysin Inhibitors on Patients With Acute Heart Failure Syndrome.

Cureus. 2025-3-24

[8]
Novel and established biomarkers to complement risk scores in patients with acute decompensated heart failure - a pilot study.

Am Heart J Plus. 2025-4-10

[9]
Short-term mortality and readmission rate prediction by the sequential organ failure assessment score in acute decompensated heart failure.

Ann Med Surg (Lond). 2024-12-27

[10]
Risk classification for long-term mortality among patients with acute heart failure: China PEACE 4YMortality.

ESC Heart Fail. 2025-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索